Deferasirox iron complex (CAS 554445-58-8)

Deferasirox iron complex is a compound formed by the chelation of iron with the chelating agent deferasirox. This complex is extensively studied in scientific research, particularly in the field of iron metabolism and iron overload disorders. Deferasirox, the primary component of this complex, is a well-known iron chelator used for transfusional iron overload in patients with conditions such as thalassemia and sickle cell disease. In research, the deferasirox iron complex has been investigated for its ability to effectively chelate iron ions and mitigate iron-mediated toxicity in various biological systems. Studies have demonstrated its potential in reducing iron-induced oxidative stress and cellular damage by sequestering excess iron and preventing its participation in harmful Fenton reactions. Furthermore, researchers have explored this complex in conditions characterized by iron overload, including neurodegenerative diseases such as Alzheimer′s and Parkinson′s disease. Additionally, the deferasirox iron complex has been utilized in studies to explain the mechanisms underlying iron metabolism and to develop novel strategies for managing iron-related disorders. Its effectiveness as an iron chelator and its potential applications make the deferasirox iron complex a valuable tool in scientific research aimed at understanding iron dysregulation disorders.